WHO/HTM/TB/2008.394

Anti-tuberculosis drug resistance in the world
Report no. 4

This report provides results of the survey conducted in 93 different countries/geographical settings, between 2002 and 2007 by WHO and the International Union Against Tuberculosis and Lung Disease global project.

Download the document [pdf 3Mb] | Executive summary [pdf 86kb]

WHO/HTM/TB/2004.343

Anti-tuberculosis drug resistance in the world
Report no. 3

This report provides results of the survey conducted in 77 different countries/geographical settings, between 1999 and 2002 by WHO and the International Union Against Tuberculosis and Lung Disease Global Project.

Download the document [html]

WHO/CDS/TB/2000.278

Anti-tuberculosis drug resistance in the world
Report no. 2

This report provides results of the survey conducted in 58 different countries/geographical settings, between 1996 and 1999 by WHO and the International Union Against Tuberculosis and Lung Disease Global Project.

Download the document [pdf 284kb]

WHO/TB/97.229

Anti-tuberculosis drug resistance in the world
Report no. 1

The report provides results of the survey conducted in 35 countries/geographical settings, between 1996 and 1999 by WHO and the International Union Against Tuberculosis and Lung Disease global project.

Download the document [2.44Mb]

Guidelines for surveillance of drug resistance in tuberculosis
WHO and the International Union Against Tuberculosis and Lung Disease

WHO/HTM/TB/2007.385

Interim recommendations for the surveillance of drug resistance in tuberculosis 2007

New recommendations have been issued for the surveillance of drug resistance in TB to provide up-to-date guidance on the design and implementation of drug-resistance surveys or surveillance systems to TB control programme managers and their staff.

The latest recommendations build on those developed in 2003, and provide additional specific information related to groups at high risk of TB infection, incorporation of second-line drug susceptibility testing, and HIV coinfection. The interim recommendations will be updated later in the year to incorporate revisions agreed by TB drug-resistant specialists attending a meeting in Geneva, Switzerland, on TB testing and drug susceptibility in July.

Download the document [pdf 189kb]

WHO/CDS/TB/2003.320

Guidelines for the surveillance of drug resistance in tuberculosis 2003

This document proposes a standard tool for tuberculosis control programmes to implement and improve the performance of anti-TB drug resistance surveillance and drug sensitivity testing.

Download the document [pdf 365kb]